![](/img/cover-not-exists.png)
Phase II Study of Irinotecan and Cetuximab Given Every 2 Weeks as Second-Line Therapy for Advanced Colorectal Cancer
Benedito A. Carneiro, Ramesh K. Ramanathan, Marwan G. Fakih, Smitha S. Krishnamurthi, Barry C. Lembersky, Ronald G. Stoller, Stewart L. Lancaster, Richard A. Pinkerton, Theodore L. Crandall, Amy R. ScVolume:
11
Year:
2012
Language:
english
Pages:
60
DOI:
10.1016/j.clcc.2011.05.003
File:
PDF, 359 KB
english, 2012